A Systematic Overview of Radiation Therapy Effects in Brain Tumours

References

• Kleihues P, Burger PC, Scheithauer BW. World Health Organization international histological classification of tu-mours: histological typing of tumors of the central nervous system, 2nd ed.. Berlin, Heidelberg: Springer-Verlag; 1993.
   Google Scholar
• Kleihues P, Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro-oncol 1999; 1: 44–51.
   PubMedGoogle Scholar
• Walker MD, Green SB, Byar DP, et al. Randomized compar-isons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980; 303: 1323–9.
   PubMed Web of Science ®Google Scholar
• Andersen AR Postoperative irradiation of glioblastomas. Results in a randomized series. Acta Radiol Oncol Radiat Phys Biol 1978; 17: 475–84.
   PubMedGoogle Scholar
• Kristiansen K, Hagen S, Kollevold T, et al. Combined modality therapy of operated astrocytomas grade III and IV. Confirma-tion of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 1981; 47: 649–52.
   Google Scholar
• Laperriere N, Zuraw L, Cairncross G. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 2002; 64: 259–73. (L1/1 773)
   PubMed Web of Science ®Google Scholar
• Scott CB. Quality-adjusted survival analysis of malignant glioma patients. Control Clin Trials 1997; 18: 277-85. (C1/786)
   Google Scholar
• Werner-Wasik M, Scott CB, Nelson DF, et al. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfrac-tionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncol-ogy Group Study 83–02. Cancer 1996; 77: 1535–43. (C1/786)
   Google Scholar
• Scott C, Curran W, Yung W, et al. Long term results of RTOG 9006: a randomized trial of hyperfractionated radiotherapy (RT) to 72.0 Gy & carmustine vs standard RT & carmustine for malignant glioma patients with emphasis on anaplastic astro-cytoma (AA) patients. ASCO 1998; Abstr 1548.
   Google Scholar
• Corn BW, Yousem DM, Scott CB, et al. White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02). Cancer 1994; 74: 2828–35. (C1/747)
   Google Scholar
• Sneed PK, McDermott MW, Gutin PH. Interstitial brachyther-apy procedures for brain tumors. Semin Surg Oncol 1997; 13: 157-66. (L1)
   Google Scholar
• Matsumoto K, Nakagawa T, Tada E, et al. Effect of adjuvant iridium-192 brachytherapy on the survival of patients with malignant gliomas. Neurol Med Chir (Tokyo) 1997; 37: 891-9. (R3/83)
   Google Scholar
• Laperriere NJ, Leung PM, McKenzie S, et al. Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 1998; 41: 1005-11. (C2/140)
   Google Scholar
• Brada M, Thomas G, Elyan S, et al. Improving the accept-ability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma. Br J Cancer 1995; 71: 1330-4. (P1/116)
   Google Scholar
• Hulshof MC, Schimmel EC, Andries Bosch D, et al. Hypo-fractionation in glioblastoma multiforme. Radiother Oncol 2000; 54: 143-8. (P1/155)
   Google Scholar
• Huncharek M. Meta-analytic re-evaluation of misonidazole in the treatment of high grade astrocytoma. Anticancer Res 1998; 18: 1935-9. (M2/1700)
   Google Scholar
• Pickles T, Goodman GB, Rheaume DE, et al. Pion radiation for high grade astrocytoma: results of a randomized study. Int J Radiat Oncol Biol Phys 1997; 37: 491-7. (C2/81)
   Google Scholar
• Donahue B, Scott CB, Nelson JS, et al. Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02. Int J Radiat Oncol Biol Phys 1997; 38: 911-4. (C1/133)
   Google Scholar
• Glinski B, Dymek P, Skolyszewski J. Altered therapy schedules in postoperative treatment of patients with malignant gliomas. Twenty-year experience of the Maria Sklodowska-Curie Mem-orial Center in Krakow, 1973-1993. J Neurooncol 1998; 36: 159–65. (R3/294)
   Google Scholar
• Karim AB, Afra D, Cornu P, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BR04: an interim analysis. Int J Radiat Oncol Biol Phys 2002; 52: 316-24. (C3/290)
   Google Scholar
• Trautmann TG, Shaw EG. Supratentorial low-grade glioma: is there a role for radiation therapy? Ann Acad Med Singapore 1996; 25: 392-6. (L1)
   Google Scholar
• Karim AB, Maat B, Hatlevoll R, et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 1996; 36: 549-56. (C1/379)
   Google Scholar
• Kiebert GM, Curran D, Aaronson NK, et al. Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group. Eur J Cancer 1998; 34: 1902-9. (C1/379)
   Google Scholar
• Kreth FW, Faist M, Rossner R, et al. The risk of interstitial radiotherapy of low-grade gliomas. Radiother Oncol 1997; 43: 253-60. (R1/594)
   Google Scholar
• Halperin EC. Malignant gliomas in older adults with poor prognostic signs. Getting nowhere, and taking a long time to do it. Oncology (Huntingt) 1995; 9: 229-34. (L2)
   Google Scholar